Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes

被引：89

作者：

de Ziegler, Dominique ^{[1
]}

Gayet, Vanessa ^{[1
]}

Aubriot, Francois Xavier ^{[1
,2
]}

Fauque, Patricia ^{[3
,4
]}

Streuli, Isabelle ^{[3
,4
]}

Wolf, Jean Philippe ^{[5
]}

de Mouzon, Jacques ^{[1
]}

Chapron, Charles ^{[1
,6
]}

机构：

[1] Univ Paris 05, Dept Obstet Gynecol & Reprod Med, CHU Cochin, AP HP, F-75014 Paris, France

[2] Cherest Ctr Reprod Med, Paris, France

[3] Univ Hosp Geneva, Dept Obstet & Gynaecol, Geneva, Switzerland

[4] Univ Geneva, Fac Med, Geneva, Switzerland

[5] Univ Paris 05, Dept Reprod Biol, CHU Cochin, AP HP, F-75014 Paris, France

[6] Cochin Inst, Paris, France

来源：

FERTILITY AND STERILITY | 2010年 / 94卷 / 07期

关键词：

ART; COH; controlled ovarian hyperstimulation; endometriomas; endometriosis; IVF; OC; oral contraceptives; EUTOPIC ENDOMETRIUM; EXPRESSION; STIMULATION; IVF;

D O I：

10.1016/j.fertnstert.2010.05.056

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

In women with endometriosis, including those with endometriomas, 6 to 8 weeks of continuous use of oral contraception (OC) before assisted reproduction treatment (ART) maintains ART outcomes comparable with the outcomes of age-matched controls without endometriosis. In contrast, ART outcomes are markedly compromised in endometriosis patients who are not pretreated with OC. Ovarian responsiveness to stimulation was not altered by 6 to 8 weeks' use of pre-ART OC, including in poor responders with endometriomas. (Fertil Steril (R) 2010; 94: 2796-9. (C) 2010 by American Society for Reproductive Medicine.)

引用

页码：2796 / 2799

页数：4

共 50 条

[31] NONCONTRACEPTIVE USE OF ORAL-CONTRACEPTIVES IN PERIMENOPAUSAL WOMEN - INTRODUCTION
CONNELL, EB
JOURNAL OF REPRODUCTIVE MEDICINE, 1993, 38 (12) : 1005 - 1006
[32] USE OF ORAL-CONTRACEPTIVES IN WOMEN OF OLDER REPRODUCTIVE AGE
MISHELL, DR
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 158 (06) : 1652 - 1657
[33] Optimizing therapy of seizures in women who use oral contraceptives
Harden, Cynthia L.
Leppik, Ilo
NEUROLOGY, 2006, 67 (12) : S56 - S58
[34] Use of oral contraceptives and risk of breast cancer in young women
Giske Ursin
Ronald K. Ross
Jane Sullivan-Halley
Rosemarie Hanisch
Brian Henderson
Leslie Bernstein
Breast Cancer Research and Treatment, 1998, 50 : 175 - 184
[35] Use of oral contraceptives and risk of breast cancer in young women
Ursin, G
Ross, RK
Sullivan-Halley, J
Hanisch, R
Henderson, B
Bernstein, L
BREAST CANCER RESEARCH AND TREATMENT, 1998, 50 (02) : 175 - 184
[36] STUDY OF THE ORAL CONTRACEPTIVES' USE BY WOMEN FROM WESTERN ROMANIA
Hepcal, Ioana Cuc
Toma, Claudia Crina
Olah, Neli
Dehelean, Cristina
Motoc, Andrei
Ardelean, Simona
Conea, Simona
Morgovan, Claudiu
FARMACIA, 2015, 63 (04) : 607 - 612
[37] NUTRIENT INTAKES OF WOMEN WHO USE ORAL-CONTRACEPTIVES
MASSE, PG
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1991, 91 (09) : 1118 - 1120
[38] Health outcomes in women taking ethinylestradiol/drospirenone and other oral contraceptives
Loughlin, Jeanne
Seeger, John
Eng, P. Mona
Clifford, C. Robin
Cutone, Jennifer
Walker, Alexander
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S72 - S73
[39] Differences between gonadotropin-releasing hormone agonist and oral contraceptives for the treatment of endometriosis
Aisaka, K
Doi, M
Ikezuki, Y
Obata, S
OBSTETRICS AND GYNECOLOGY, 2005, 105 (04): : 63S - 63S
[40] Serum Lipid Levels and Treatment Outcomes in Women Undergoing Assisted Reproduction: A Retrospective Cohort Study
Cai, Wang-Yu
Luo, Xi
Chen, Erxidi
Lv, Houyi
Fu, Kaiyou
Wu, Xiao-Ke
Xu, Jian
FRONTIERS IN ENDOCRINOLOGY, 2021, 12

← 1 2 3 4 5 →